Capital Investment Counsel Inc’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$233K Buy
+1,816
New +$213K 0.03% 192
2026
Q1
Sell
-4,100
Closed -$432K 265
2025
Q4
$432K Buy
4,100
+79
+2% +$7.42K 0.05% 134
2025
Q3
$337K Hold
4,021
0.04% 153
2025
Q2
$318K Sell
4,021
-100
-2% -$7.95K 0.04% 150
2025
Q1
$370K Hold
4,121
0.06% 130
2024
Q4
$410K Buy
4,121
+40
+1% +$4.12K 0.06% 121
2024
Q3
$463K Hold
4,081
0.07% 119
2024
Q2
$505K Hold
4,081
0.08% 108
2024
Q1
$538K Hold
4,081
0.09% 106
2023
Q4
$445K Hold
4,081
0.08% 117
2023
Q3
$420K Hold
4,081
0.08% 116
2023
Q2
$471K Sell
4,081
-140
-3% -$15.9K 0.09% 107
2023
Q1
$449K Hold
4,221
0.1% 107
2022
Q4
$468K Buy
+4,221
New +$431K 0.11% 106
2022
Q3
Sell
-4,081
Closed -$372K 188
2022
Q2
$372K Hold
4,081
0.09% 120
2022
Q1
$335K Hold
4,081
0.07% 134
2021
Q4
$313K Sell
4,081
-941
-19% -$75K 0.06% 145
2021
Q3
$377K Hold
5,022
0.08% 121
2021
Q2
$391K Sell
5,022
-141
-3% -$10.5K 0.09% 122
2021
Q1
$380K Buy
+5,163
New +$381K 0.1% 115
2020
Q4
Sell
-5,263
Closed -$417K 185
2020
Q3
$417K Buy
+5,263
New +$412K 0.12% 92
2020
Q2
Sell
-5,263
Closed -$386K 171
2020
Q1
$386K Buy
5,263
+8
+0.2% +$629 0.16% 90
2019
Q4
$456K Buy
5,255
+349
+7% +$28.7K 0.15% 95
2019
Q3
$394K Sell
4,906
-104
-2% -$8.34K 0.14% 101
2019
Q2
$401K Hold
5,010
0.14% 104
2019
Q1
$398K Hold
5,010
0.15% 102
2018
Q4
$365K Buy
5,010
+209
+4% +$14.8K 0.16% 95
2018
Q3
$325K Sell
4,801
-255
-5% -$16.2K 0.12% 106
2018
Q2
$293K Hold
5,056
0.12% 107
2018
Q1
$263K Buy
5,056
+669
+15% +$36.1K 0.11% 116
2017
Q4
$236K Hold
4,387
0.1% 127
2017
Q3
$268K Sell
4,387
-734
-14% -$44.5K 0.12% 118
2017
Q2
$313K Sell
5,121
-419
-8% -$25.5K 0.14% 107
2017
Q1
$336K Hold
5,540
0.15% 102
2016
Q4
$311K Hold
5,540
0.15% 103
2016
Q3
$330K Sell
5,540
-105
-2% -$6.14K 0.16% 100
2016
Q2
$310K Sell
5,645
-628
-10% -$33.4K 0.16% 101
2016
Q1
$317K Sell
6,273
-804
-11% -$39.4K 0.16% 102
2015
Q4
$357K Hold
7,077
0.19% 98
2015
Q3
$334K Buy
7,077
+489
+7% +$26K 0.18% 101
2015
Q2
$358K Sell
6,588
-1,285
-16% -$72.1K 0.18% 101
2015
Q1
$432K Hold
7,873
0.2% 95
2014
Q4
$427K Sell
7,873
-409
-5% -$22.8K 0.21% 95
2014
Q3
$468K Sell
8,282
-1,274
-13% -$71.5K 0.23% 93
2014
Q2
$527K Sell
9,556
-524
-5% -$28.6K 0.23% 102
2014
Q1
$546K Buy
10,080
+315
+3% +$16.3K 0.24% 97
2013
Q4
$466K Hold
9,765
0.21% 106
2013
Q3
$444K Sell
9,765
-105
-1% -$4.79K 0.22% 104
2013
Q2
$437K Buy
+9,870
New +$441K 0.23% 105

Other funds holding MRK

Capital Investment Counsel Inc's MRK Position: Q2 2026 in Review

Capital Investment Counsel Inc opened a new position in Merck (MRK) in Q2 2026: 1,816 shares worth $233K. The stake represents 0.03% of the portfolio and ranks #192 among its holdings. This is a return to the name: Capital Investment Counsel Inc previously reported a position in MRK as recently as Q4 2025.

Capital Investment Counsel Inc first reported a position in MRK in Q2 2013 and has held it in 49 quarters since. The position peaked at $546K in Q1 2014. 2,475 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Capital Investment Counsel Inc held 1,816 shares of Merck worth $233K as of Q2 2026.
  • Merck was a new Capital Investment Counsel Inc position in Q2 2026.
  • Merck made up 0.03% of Capital Investment Counsel Inc's portfolio in Q2 2026, its #192 holding.
  • Capital Investment Counsel Inc first reported a position in Merck in Q2 2013 and has held it in 49 quarters since.
  • Capital Investment Counsel Inc's Merck position peaked at $546K in Q1 2014.
  • 2,475 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Capital Investment Counsel Inc's 13F filing for Q2 2026, filed 27 Jul 2026.